Abbott Gains FDA Approval for 'Enhancements' to HIV-1 Test | GenomeWeb
NEW YORK (GenomeWeb News) - Abbott said Thursday it has received supplemental pre-market approval from the US Food and Drug Administration for improvements to its RealTime HIV-1 viral load test, which runs on its m2000 RT PCR platform.
 
The FDA initially cleared the test in May.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.